Avant Bio
Founded in 2023, Avant Bio is a New York-based venture capital firm focusing on early-stage and growth equity investments in Life Sciences, TechBio, Healthtech, and Diagnostics. It aims to capitalize on opportunities arising from the intersection of technology and biology.
Top Regions
3 past transactions
Nomic
Series B in 2024
Nomic is a bioengineering company developing the nELISA platform for measuring proteins at scale and high throughput. They offer protein profiling solutions empowering scientists to decide experiment scope and scale.
PathPresenter
Series A in 2024
PathPresenter is a global platform facilitating secure and compliant sharing of pathology images among professionals. Its mission is to enhance collaboration and patient care by connecting pathologists worldwide.
PL BioScience
Series A in 2024
Founded in 2015, PL BioScience specializes in manufacturing high-quality cell culture products based on human platelet lysate for stem cell research. Its portfolio includes research-grade, GMP-grade, and customized products, along with support services. The company's offerings cater to various applications, from basic research to clinical applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.